Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Jilin Jian Yisheng Pharmaceutical Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Jilin Jian Yisheng Pharmaceutical has a total shareholder equity of CN¥2.3B and total debt of CN¥470.4M, which brings its debt-to-equity ratio to 20.3%. Its total assets and total liabilities are CN¥3.0B and CN¥688.6M respectively. Jilin Jian Yisheng Pharmaceutical's EBIT is CN¥67.3M making its interest coverage ratio -13.7. It has cash and short-term investments of CN¥550.7M.
Anahtar bilgiler
20.3%
Borç/özkaynak oranı
CN¥470.39m
Borç
| Faiz karşılama oranı | -13.7x |
| Nakit | CN¥550.73m |
| Eşitlik | CN¥2.32b |
| Toplam yükümlülükler | CN¥688.59m |
| Toplam varlıklar | CN¥3.00b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 002566's short term assets (CN¥2.4B) exceed its short term liabilities (CN¥415.6M).
Uzun Vadeli Yükümlülükler: 002566's short term assets (CN¥2.4B) exceed its long term liabilities (CN¥273.0M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 002566 has more cash than its total debt.
Borcun Azaltılması: 002566's debt to equity ratio has increased from 18.4% to 20.3% over the past 5 years.
Borç Kapsamı: 002566's debt is well covered by operating cash flow (29.1%).
Faiz Kapsamı: 002566 earns more interest than it pays, so coverage of interest payments is not a concern.